Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP287197.RAj49Tq6fQVFysLJaog5vioMbawcrEHnbzmYR9aq7s_hU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP287197.RAj49Tq6fQVFysLJaog5vioMbawcrEHnbzmYR9aq7s_hU130_assertion type Assertion NP287197.RAj49Tq6fQVFysLJaog5vioMbawcrEHnbzmYR9aq7s_hU130_head.
- NP287197.RAj49Tq6fQVFysLJaog5vioMbawcrEHnbzmYR9aq7s_hU130_assertion description "[Here, we report that flufenamic acid shows two opposing effects on COX-2 expression; it induces COX-2 expression in the colon cancer cell line (HT-29) and macrophage cell line (RAW 264.7); conversely, it inhibits tumor necrosis factor alpha (TNFalpha)- or lipopolysaccharide (LPS)-induced COX-2 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP287197.RAj49Tq6fQVFysLJaog5vioMbawcrEHnbzmYR9aq7s_hU130_provenance.
- NP287197.RAj49Tq6fQVFysLJaog5vioMbawcrEHnbzmYR9aq7s_hU130_assertion evidence source_evidence_literature NP287197.RAj49Tq6fQVFysLJaog5vioMbawcrEHnbzmYR9aq7s_hU130_provenance.
- NP287197.RAj49Tq6fQVFysLJaog5vioMbawcrEHnbzmYR9aq7s_hU130_assertion SIO_000772 10866999 NP287197.RAj49Tq6fQVFysLJaog5vioMbawcrEHnbzmYR9aq7s_hU130_provenance.
- NP287197.RAj49Tq6fQVFysLJaog5vioMbawcrEHnbzmYR9aq7s_hU130_assertion wasDerivedFrom befree-2016 NP287197.RAj49Tq6fQVFysLJaog5vioMbawcrEHnbzmYR9aq7s_hU130_provenance.
- NP287197.RAj49Tq6fQVFysLJaog5vioMbawcrEHnbzmYR9aq7s_hU130_assertion wasGeneratedBy ECO_0000203 NP287197.RAj49Tq6fQVFysLJaog5vioMbawcrEHnbzmYR9aq7s_hU130_provenance.